ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Pharmarise Holdings Corp. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 3.11% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Poor long term growth as Net Sales has grown by an annual rate of 3.11% over the last 5 years
3
The company has declared Negative results for the last 5 consecutive quarters
- CASH AND EQV(HY) Lowest at JPY 7,154 MM
- DEBT-EQUITY RATIO (HY) Highest at 136.38 %
- INVENTORY TURNOVER RATIO(HY) Lowest at 16.29%
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -10.61%, its profits have fallen by -135.8%
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -10.61% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Pharmarise Holdings Corp. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Pharmarise Holdings Corp.
-10.61%
-0.90
18.91%
Japan Nikkei 225
28.54%
1.11
25.75%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.11%
EBIT Growth (5y)
-33.14%
EBIT to Interest (avg)
16.35
Debt to EBITDA (avg)
2.65
Net Debt to Equity (avg)
1.73
Sales to Capital Employed (avg)
3.12
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.02%
ROE (avg)
5.48%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.83
EV to EBIT
118.54
EV to EBITDA
11.57
EV to Capital Employed
0.94
EV to Sales
0.29
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.79%
ROE (Latest)
-2.20%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
NET SALES(Q)
Highest at JPY 16,929 MM
OPERATING PROFIT(Q)
Highest at JPY 606 MM
OPERATING PROFIT MARGIN(Q)
Highest at 3.58 %
PRE-TAX PROFIT(Q)
Highest at JPY 236 MM
-27What is not working for the Company
CASH AND EQV(HY)
Lowest at JPY 7,154 MM
DEBT-EQUITY RATIO
(HY)
Highest at 136.38 %
INVENTORY TURNOVER RATIO(HY)
Lowest at 16.29%
INTEREST(Q)
Highest at JPY 59 MM
NET PROFIT(Q)
Lowest at JPY -646 MM
Here's what is working for Pharmarise Holdings Corp.
Pre-Tax Profit
At JPY 236 MM has Grown at 6,642.86%
over average net sales of the previous four periods of JPY 3.5 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (JPY MM)
Net Sales
Highest at JPY 16,929 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (JPY MM)
Net Sales
At JPY 16,929 MM has Grown at 12.17%
over average net sales of the previous four periods of JPY 15,092.75 MMMOJO Watch
Near term sales trend is positive
Net Sales (JPY MM)
Operating Profit
Highest at JPY 606 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (JPY MM)
Operating Profit Margin
Highest at 3.58 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at JPY 236 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (JPY MM)
Depreciation
Highest at JPY 408 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (JPY MM)
Here's what is not working for Pharmarise Holdings Corp.
Net Profit
At JPY -646 MM has Fallen at -1,656.74%
over average net sales of the previous four periods of JPY -36.77 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (JPY MM)
Interest
At JPY 59 MM has Grown at 15.69%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Interest
Highest at JPY 59 MM
in the last five periods and Increased by 15.69% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Net Profit
Lowest at JPY -646 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (JPY MM)
Cash and Eqv
Lowest at JPY 7,154 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at 136.38 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Inventory Turnover Ratio
Lowest at 16.29%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
